GO
Loading...

Roche's Tamiflu for children temporarily in short supply

Image Source | Getty Images

In what is shaping up to be a tough and widespread flu season in the United States, one of the leading medicines used to treat children with the sometimes deadly virus is in short supply.

"There has been strong and early demand for Tamiflu Oral Suspension [OS] and we are experiencing a temporary delay in the packaging of Tamiflu OS,'' said Tara Iannuccillo, a spokeswoman for Roche Holding AG's Genentech unit, which makes the drug.

"A brief shortage of OS is expected through mid-January," she said. "We may be unable to fill complete orders from distributors for a limited time,.'

(Read more: The cost of flu remedies could make you sick)

Tamiflu is used to reduce the severity of the flu when taken at the onset of symptoms. The oral suspension of the drug is primarily prescribed for children under 13 and for adults who have difficulty swallowing.

The delay in packaging of the liquid version has not affected supplies of regular Tamiflu 75 milligram capsules, Genentech said.

The flu is spreading quickly this season, with 25 states already reporting cases, according to the Centers for Disease Control and Prevention.

(Read more: Is another $30 billion flu season at hand?)

Thousands of people die every year from flu, which typically peaks in the United States between the months of October and March. Six children have died from the flu so far, according to CDC data.

Roche said it expects to have additional supply of Tamiflu OS available in mid-January.

"We expect that these new supplies should meet demand for OS overall, and we will continue to receive and ship out new supplies of Tamiflu OS and capsules throughout the flu season," Iannuccillo said.

(Read more: Efforts to pass paid sick leave laws face backlash)

If the drug is unavailable in a particular area during the shortage, pharmacists can mix the capsules into an oral suspension.

Meanwhile, the CDC recommends that people get flu shots to prevent the virus.

"We are seeing a big uptick in disease in the past couple of weeks,'' Dr. Joe Bresee, chief of epidemiology and prevention in the CDC's influenza division, said last week.

"There is still a lot of season to come. If folks haven't been vaccinated, we recommend they do it now,'' he said.

—By Reuters

Contact Health Care

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    › Learn More